Results 131 to 140 of about 2,148,975 (183)

Rare case report and literature review of peripheral T-cell lymphoma presenting as massive gastrointestinal hemorrhage: an unusual etiology demanding emergency surgical intervention. [PDF]

Front Oncol
Liu Z, Zhang L, Chen Q, He H, Xiong Y, Peng W, Liu Y, Li G, Zhan L.   +8 more
europepmc   +1 more source

Peripheral T-cell Lymphoma in Japan: Real-World Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs. [PDF]

J Health Econ Outcomes Res
Dharmani C, Fofah O, Qu P, Jiang Z, Wang J, Li L, Tao Y, Song L.   +7 more
europepmc   +1 more source

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study. [PDF]

Blood Adv
Ruan J, Chen Z, Larson MC, Bennani NN, Allen P, Mou E, Wallace D, Mehta-Shah N, Lossos IS, Malpica Castillo LE, Jaye DL, Vega F, Inghirami G, Pongas G, Akkad N, Casulo C, Martin P, Cohen JB, Habermann TM, Maurer MJ, Leonard JP, Friedberg JW, Kahl B, Cerhan JR, Flowers CR, Feldman AL.   +25 more
europepmc   +1 more source

Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients. [PDF]

Ann Hematol
Chen ZT, Huang L, Zhang XD, Wang N, Jiang XM, Wei XJ, Zhang H, Guo HG, Lin CD, Chen FL, Liu SC, Liang ZL, Li WY.   +12 more
europepmc   +1 more source

Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report. [PDF]

Cureus
Ota H, Arihiro K, Mihara K, Chikama TI.
europepmc   +1 more source

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26). [PDF]

Blood Cancer J
Wei J, Cai Q, Zhang L, Zou L, Li Z, Zhou K, Wu H, Qiu L, Su L, Ding K, Zhou H, Yu L, Li F, Li W, Lin L, Xiao Q, Wang E, Jing H, Zheng M, Zhang H, Gao Y, Gao D, Chen L, Jin J.   +23 more
europepmc   +1 more source

Immunomorphological Analysis of the CD40-CD154 Interaction in T Follicular Helper Cell Lymphoma Emphasizes the Significance of the CD40-CD154 Axis in the Disease. [PDF]

Cells
Janotka DM, Borbényi Z, Piukovics K, Bukva M, Bakos A, Bagdi E, Krenács L.   +6 more
europepmc   +1 more source

Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party. [PDF]

Hemasphere
Shumilov E, Ngoya M, Berning P, Khvedelidze I, Serroukh Y, Wondergem M, Cwynarski K, Thurner L, Wahlin BE, Zeiser R, Hazenberg C, Nicholson E, Remenyi P, Netelenbos T, Lenhoff S, Tournilhac O, Wilson K, Ho A, Lenz G, Wulf G, Glass B, Dreger P, Sureda A, Damaj G, Bazarbachi A, Schmitz N.   +25 more
europepmc   +1 more source

From Cell Lines to Avatars: Charting the Future of Preclinical Modeling in T-Cell Malignancies. [PDF]

Cells
Piccaluga PP, Cimmino L, Tsekhovska V, Cimatti P, Innocenti C, Seidenari S, Calafato G, Di Paola FJ, Tallini G.   +8 more
europepmc   +1 more source

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma. [PDF]

Blood Adv
Gordon MJ, Miljkovic MD, Milhon P, Lakhotia R, Melani C, Johnson K, Bryant B, Pittaluga S, Jaffe ES, Conlon K, Staudt LM, Wilson WH, Roschewski M, Ng S.   +13 more
europepmc   +1 more source